At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
The reports will now be shared with relevant ministries and departments as a guidance framework
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Subscribe To Our Newsletter & Stay Updated
